Xigris (Drotrecogin alfa) is not an antibiotic but is approved for the specific indication of sepsis because of its anticoagulant properties.
Xigris (Drotrecogin alfa) is a drug approved by the Food and Drug Administration for the reduction of mortality in adult patients with severe sepsis who have a high risk of death. Xigris (Drotrecogin alfa) is placed under the class of serine proteases and it has anticoagulant, anti-thrombotic, anti-inflammatory, and profibrinolytic properties.
If all the droplets were the same size, the droplet with the smallest charge <span>would fall most slowly through the apparatus. Basically, buoyancy is the same for all droplets but the electrical force would be different for each. The higher the electrical force the greater is the gravitational pull towards that droplet. Therefore, the droplet that has the </span>smallest charge<span> would drop most slowly.</span>
